~~<i id='4DCAF560B7'><strike id='4DCAF560B7'><tt id='4DCAF560B7'><pre id='4DCAF560B7'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

fashion

author：Wikipedia 2025-10-01 23:00:12 - browse：73

The FDA building -- First Opinion coverage from STAT — Adobe

WASHINGTON — The Food and Drug Administration’s top cancer drug regulator doesn’t always ask for permission before taking on big initiatives.

Richard Pazdur, director of the FDA Oncology Center of Excellence, hates bureaucracy. It stifles his ideas for getting treatments to cancer patients faster — of which there are many.

To cut through that bureaucracy, Pazdur has a trick: “Don’t tell anybody,” he said to laughter at a meeting of the advocacy group Friends of Cancer Research Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Behind warning on Apellis’s eye drug lies a conflict of interest

focus

hotspot

entertainment

RedCrossvolunteersdelivermealsattheRollingForkMotel,wheredisplacedfamiliesarelivingaftertheirhomeswe

WSS

Marc Tessier

What don’t we know about an Alzheimer’s drug side effect?

An outrageous hospital charge: I paid $710 for an hour of babysitting

Ending health disparities requires full federal government, panel says

Fetal surgery at risk from Dobbs and new abortion restrictions

Ending health disparities requires full federal government, panel says

focus

fashion

focus

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

The EPA's new lead rule: How one expert crunched the numbers

Medicare details structure of new drug price negotiation program

J&J to emphasize cancer drugs, stop much of its vaccine research

Apple is now the first public company to be valued at $3 trillion

With clinical trial data readouts, here's how to spot spin

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Trader Joe's recalls 10K cases of broccoli cheddar soup over potential foreign material

As demand for Covid shots wanes, Moderna seeks its next success

CDC director unscathed in first congressional testimony

focus

As the dark side of IVF slowly comes into focus, even more transparency is needed

Hospitals, health systems can help patients avoid medical debt

Ford recalls 870K F

CDC director unscathed in first congressional testimony

Pediatric cancer treatments threatened by a new FDA policy

With clinical trial data readouts, here's how to spot spin

hotspot

hotspot

hotspot

entertainment